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Huntingtin-interacting protein family members are evolutionarily
conserved from yeast to humans, and they are known to be key
factors in clathrin-mediated endocytosis. Here we identified the
Caenorhabditis elegans protein huntingtin-interacting protein-
related 1 (HIPR-1) as a host factor essential for Orsay virus infec-
tion of C. elegans. Ablation of HIPR-1 resulted in a greater than
10,000-fold reduction in viral RNA, which could be rescued by ec-
topic expression of HIPR-1. Viral RNA replication from an endoge-
nous transgene replicon systemwas not affected by lack of HIPR-1,
suggesting that HIPR-1 plays a role during an early, prereplication
virus life-cycle stage. Ectopic expression of HIPR-1 mutants dem-
onstrated that neither the clathrin light chain-binding domain nor
the clathrin heavy chain-binding motif were needed for virus in-
fection, whereas the inositol phospholipid-binding and F-actin–binding
domains were essential. In human cell culture, deletion of the hu-
man HIP orthologs HIP1 and HIP1R led to decreased infection by
Coxsackie B3 virus. Finally, ectopic expression of a chimeric HIPR-1
harboring the human HIP1 ANTH (AP180 N-terminal homology) do-
main rescued Orsay infection in C. elegans, demonstrating conser-
vation of its function through evolution. Collectively, these findings
further our knowledge of cellular factors impacting viral infection in
C. elegans and humans.
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The identification of novel cellular factors that promote viralinfection is key to advancing our understanding of the viral
life cycle, and it has the potential to yield new therapeutic tar-
gets. The multicellular model organism Caenorhabditis elegans is
naturally infected by Orsay virus, a positive-sense, nonenveloped
RNA virus (1). This infection system has recently been utilized to
identify several novel host factors that are essential for Orsay
virus infection (2, 3). Through an unbiased forward genetic
screen, the genes sid-3, viro-2, and drl-1 were previously identi-
fied as host factors essential at an early stage of the Orsay virus
life cycle (2, 3). This genetic screen utilized the jyIs8;rde-1(ne219)
reporter strain, which expresses green fluorescent protein (GFP)
under control of the virus-inducible gene promoter pals-5 (2). In
the rde-1 mutant genetic background, which renders these ani-
mals hypersensitive to Orsay virus, virus infection typically leads
to GFP expression in greater than 99% of animals. In this screen,
following chemical mutagenesis, mutants that fail to express GFP
fluorescence are selected (2). C. elegans nck-1 is an additional
critical factor for Orsay virus infection identified through an
RNA interference (RNAi)-based reverse genetic screen target-
ing host factors interacting with the mammalian orthologs of sid-
3 and viro-2 (2). Moreover, the human orthologs of sid-3, viro-2,
and nck-1 (TNK2, WASP, and NCK1, respectively) form a
pathway that is important for infection by multiple viruses in the
family Picornaviridae (3). In total, these studies establish that key
pro-viral genes discovered in C. elegans may have evolutionarily
conserved functions in mammals.
C. elegans huntingtin-interacting protein-related 1 (HIPR-1)
belongs to the huntingtin-interacting protein (4) family, members
of which have been studied in yeast and mammals. HIP-family
proteins have a common domain architecture which includes an
inositol phospholipid-binding AP180 N-terminal homology do-
main (ANTH) (5), a clathrin heavy chain-binding motif adjacent
to a central clathrin light chain-binding coiled-coil (CC) domain,
and a talin-HIP1/R/Sla2p actin-tethering C-terminal homology
(THATCH) domain, which are thought to link the F-actin cyto-
skeleton and the clathrin-mediated endocytosis pathways (6–12).
Biochemical and genetic evidence demonstrate that yeast and
human HIP-family genes bind and colocalize with clathrin endo-
cytic machinery during endocytosis, and that deletion of the yeast
HIP-family member Sla2p or knockdown of the human HIP1R
protein results in defects in clathrin-mediated endocytosis (6–12).
However, HIPR-1’s biological role in C. elegans has not been
well-studied. C. elegans HIPR-1 is predicted by homology to have
all of the canonical domains characteristic of HIP-family mem-
bers, although no functional studies of these domains have been
reported. HIPR-1 modulates presynaptic activity and the abun-
dance of the synaptic vesicle fusion regulator synaptobrevin (13).
In addition, a genome-wide RNAi screen suggests that HIPR-1
may be a regulator of the apical membrane peptide transporter
PEPT-1 (14).
C. elegans HIPR-1 shares 33 and 34% amino acid identity with
two human paralogs, HIP1 and HIP1R, respectively. The human
HIP1 and HIP1R share 48% amino acid sequence identity with
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each other (15). C. elegansHIPR-1 is more distantly related to its
yeast ortholog Sla2p (15). Mice deficient in HIP1R exhibit viable
and fertile (16), although one study identified a gastric parietal
defect associated with transformation and hypertrophy of the
glandular epithelium (17). HIP1-deficient mice, on the other
hand, exhibit testicular degeneration, spinal defects, hemato-
poietic abnormalities, and cataracts (18, 19); in a separate study,
an additional defect in AMPA receptor internalization in pri-
mary neurons was reported while hematopoiesis was normal
(20). Mice deficient in both HIP1 and HIP1R exhibited aggra-
vated spinal abnormalities and dwarfism, suggesting existence of
a compensatory role of HIP1 and HIP1R (21). HIP proteins may
be more functionally diverse than previously described, as studies
in human cell culture have also suggested human HIP proteins
may play a role in other cellular pathways such as androgen re-
ceptor transcription and apoptosis (22, 23). Only a few studies
have investigated the potential role of mammalian HIP1 and
HIP1R in virus infection (24–26). In the context of small inter-
fering RNA (siRNA) screens, HIP1R has been reported as an
important host factor for infection by Venezuelan equine en-
cephalitis virus (26), while both HIP1 and HIP1R have been
reported as important factors for hepatitis C virus, polio virus,
and Coxsackie B3 virus (CVB3) infection (24, 25). However,
little is known mechanistically about how these proteins promote
virus infection.
Here we characterize a function of HIPR-1 as a host factor
essential for Orsay virus infection. Its pro-viral function was
dependent upon both its ANTH and THATCH domains but not
its clathrin-binding domains. We demonstrated that the ANTH
domain function is conserved from C. elegans to humans, as the
human ANTH domain could replace the C. elegans ANTH do-
main. Deletion of the mammalian orthologs HIP1 and HIP1R in
human cells led to reduced infection of CVB3, which further
demonstrates the evolutionarily conserved pro-viral role this
family plays. Collectively, this study provides insights into the
mechanism of HIP proteins in virus infection, which appears to
be clathrin binding-independent.
Results
In Vivo Mutagenesis Screen for Mutants Resistant to Orsay Virus
Infection. To discover new host factors that Orsay virus relies
upon for infection, an EMS (ethylmethanesulfonate) chemical
mutagenesis screen was performed on ∼2,000 haploid genomes
in the WUM28 jyIs8;rde-1(ne219) worm reporter strain as pre-
viously described (2) (SI Appendix, Materials and Methods). Two
Viro (virus-induced reporter off) mutant strains, Viro-5 and
Viro-6, demonstrated a defect in GFP expression upon Orsay
virus challenge at 3 d post infection (dpi) (Fig. 1A). However,
when these mutants were challenged with Nematocida parisii, a
natural fungal pathogen of C. elegans that also activates the GFP
transcriptional reporter, both Viro-5 and Viro-6 displayed wild-
type levels of GFP in response to fungal infection, demonstrating
a virus-specific defect in GFP activation (Fig. 1A). Orsay RNA
replication was quantified by quantitative real-time RT-PCR at 3
dpi and revealed a reduction of greater than 10,000-fold in both
Viro-5 and Viro-6 mutants compared with the unmutagenized
parental strain (Fig. 1B).
To determine whether Viro-5 and Viro-6 fell into the same
genetic complementation group, they were crossed with each
other. Viro-5 and Viro-6 fell into the same complementation
group, suggesting they harbor independent mutant alleles of the
same gene (SI Appendix, Fig. S1).
Two Independent Mutant Alleles of hipr-1 Are Responsible for the
Virus Resistance Phenotype. Two independent approaches were
used in parallel to map the phenotype-causing mutations in Viro-
5 and Viro-6. In the first approach, F2 bulk segregant analysis
was performed on Viro-6 as previously described (2, 27) (SI
Appendix, Materials and Methods). In the second approach, the
original Viro-5 and Viro-6 mutant strains were each subjected to
whole-genome sequencing (SI Appendix, Materials and Methods).
Both approaches yielded hipr-1 as the candidate causal gene.
hipr-1 in Viro-5 harbored a candidate G-to-A nonsense mutation
that converts an arginine at position 515 to a premature stop, and
hipr-1 in Viro-6 contained a candidate G-to-A missense mutation
that results in a G773E amino acid substitution (Fig. 2A).
To determine whether hipr-1 was the causal gene for the Viro-5
and Viro-6 phenotypes, we tested the impact of RNAi knockdown
Fig. 1. Chemical mutagenesis screen identified mutant strains with a defect
in GFP expression and Orsay viral RNA replication. (A) GFP reporter expres-
sion of Viro mutants infected with Orsay virus or N. parisii at 3 dpi.
Pmyo2::mCherry is a transgenic marker. (Scale bar, 100 μm.) BF, bright field.
(B) Orsay virus RNA2 levels quantified by real-time qRT-PCR at 3 dpi. The
means and SDs for three replicates representative of at least two indepen-
dent biological experiments are shown. Statistically significant differences
were determined by Student’s t test. ***P < 0.001.



























































of hipr-1 on Orsay virus RNA levels. RNAi knockdown of hipr-1
was performed in the drh-1 mutant background. The drh-1 mutant
strain is competent for exogenous feeding RNAi yet is hypersen-
sitive to Orsay virus infection due to a defect in antiviral RNAi;
this strain provides a larger dynamic range to measure changes in
Orsay virus RNA levels than the wild-type N2 (2). At 2 dpi, Orsay
virus RNA levels were reduced by over 1,000-fold compared with
the empty vector and nonrelevant gene control dpy-3, supporting
hipr-1 as the causal gene (Fig. 2B). As an independent validation,
we ectopically expressed the genomic locus of hipr-1 under the
control of the constitutively active sur-5 gene promoter in both
Viro-5 and Viro-6. At 3 dpi, wild-type levels of GFP expression
and Orsay RNA replication were observed in both transgenic
strains, collectively demonstrating that the mutations in hipr-1 were
responsible for the Viro phenotypes (SI Appendix, Fig. S2 A and
B). Thus, Viro-5 and Viro-6 will be referred to as hipr-1(vir12) and
hipr-1(vir13), respectively, hereafter.
HIPR-1 Inositol Phospholipid- and F-Actin–Binding Domains Are
Required for Orsay Virus Infection. To explore which HIPR-1 do-
mains are important for Orsay virus infection, the following
HIPR-1 expression constructs harboring deletions were gener-
ated (Fig. 3 A and B): the HIPR-1 ANTH deletion (ΔANTH),
which is predicted to abolish binding to inositol phospholipids (9,
10); the HIPR-1 coiled-coil domain (ΔCC), which is predicted to
abolish binding to the clathrin light chain (28, 29); the HIPR-1
THATCH deletion (ΔTHATCH), which is predicted to abolish
binding to F-actin (30, 31); a deletion of the clathrin heavy chain-
binding motif LLNLA (ΔCHC), which is predicted to abolish
binding to the clathrin heavy chain, as this consists of the type I
consensus clathrin box (LL/I)(D/E/N)(L/F)(D/E) (32, 33); and a
double deletion (ΔCHCΔCC) of both the clathrin heavy chain-
binding motif and the clathrin light chain-binding coiled-coil
domain. All mutations were generated in the HIPR-1 expression
construct described above fused with mCherry as an expression
Fig. 2. hipr-1 mutant alleles and RNAi knockdown. (A) A hipr-1 genomic
structure schematic showing the position and identity of hipr-1 mutant al-
leles in Viro-5 and Viro-6. The coding region is represented in blue, un-
translated region sequences are in gray, and introns are represented as lines.
*, stop codon. (B) qRT-PCR of Orsay virus RNA2 levels 2 dpi of Orsay virus
infection of drh-1 animals fed with RNAi against targeted genes, non-
targeted genes, or empty vector. The means and SDs for three replicates
representative of at least two independent biological experiments are
shown. Statistically significant differences were determined by one-way
ANOVA with a statistical difference identified between the empty vector
and hipr-1 by Dunnett’s multiple-comparison test. **P < 0.01; NS, not sig-
nificant (P > 0.05).
Fig. 3. HIPR-1 domain structure and evolutionary conservation of HIP pro-
teins. (A) A schematic depicting HIPR-1’s three predicted evolutionarily
conserved domains and clathrin heavy chain-binding type I consensus cla-
thrin box. (B) A schematic depicting the deletions or mutations that were
introduced into the HIPR-1 expression construct, which were all mCherry-
tagged at the C terminus for visualization of expression. Numbers repre-
sent the amino acids deleted. (C) Neighbor-joining phylogenetic tree for HIP
proteins across species. The scale bar represents amino acid substitution.



















































marker, and quantification of the mCherry signal showed all strains
were expressed at comparable levels as the wild-type HIPR-
1::mCherry strain or higher (SI Appendix, Fig. S3). Ectopic ex-
pression of wild-type HIPR-1::mCherry, HIPR-1::mCherry(ΔCHC),
HIPR-1::mCherry(ΔCC), or HIPR-1::mCherry(ΔCHCΔCC) in
hipr-1(vir12) was sufficient to rescue both GFP expression and
Orsay virus RNA replication at 3 dpi, suggesting both HIPR-1’s
clathrin light chain-binding domain and clathrin heavy chain-
binding motif were dispensable for Orsay virus infection (Fig. 4).
By contrast, ectopic expression of HIPR-1::mCherry(ΔANTH) or
HIPR-1::mCherry(ΔTHATCH) in hipr-1(vir12) mutants failed to
rescue GFP expression and Orsay virus RNA replication at 3 dpi,
implicating inositol phospholipid and F-actin binding as key
functions of HIPR-1 in virus infection in C. elegans (Fig. 4 A
and B).
As four tyrosines in the human HIP1 ortholog were previously
reported to be phosphorylated by the receptor tyrosine kinase
epidermal growth factor receptor (23) and this phosphorylation
was important for cell survival, we investigated whether phos-
phorylation of the analogous tyrosines in C. elegans HIPR-1 af-
fects Orsay virus infection. As three of these tyrosines were
conserved in HIPR-1, we engineered a triple tyrosine-to-phe-
nylalanine (Y-F) nonphosphorylatable mutant form of HIPR-1
(Fig. 3B). Ectopic expression of HIPR-1(3xY-F) in hipr-1(vir12)
was sufficient to rescue both GFP expression and Orsay virus
RNA replication at 3 dpi (Fig. 4 A and B), suggesting that phos-
phorylation (or lack thereof) of these three tyrosines in HIPR-1
does not impact Orsay virus infection.
HIPR-1 Affects Orsay Virus at an Early, Prereplication Step of
Infection. To investigate which stage of the Orsay virus life cy-
cle HIPR-1 affects, an endogenous inducible viral RNA trans-
gene replicon system was generated in hipr-1(vir12) as previously
described (2). These transgenic strains carry an extrachromosomal
Fig. 4. GFP reporter expression and virus RNA replication in hipr-1(vir12) transgenic animals overexpressing various HIPR-1::mCherry constructs. (A) Intestinal
GFP expression at 3 dpi of transgenic animals infected with Orsay virus. The Pmyo2::YFP plasmid was coinjected as a transgenic marker and is observed as GFP
in the pharynx of transgenic animals. (Scale bar, 100 μm.) (B) Orsay virus RNA2 levels at 3 dpi in transgenic hipr-1(vir12) animals overexpressing HIPR-
1::mCherry constructs containing a variety of mutations. (C) Orsay virus RNA2 levels at 3 dpi in transgenic hipr-1(vir12) animals overexpressing HIPR-
1::mCherry constructs lacking the clathrin heavy chain motif, coiled-coil domain, or both. The means and SDs for three replicates representative of at least two
independent biological experiments are shown. Statistically significant differences were determined by one-way ANOVA with a statistical difference iden-
tified between three post hoc comparisons analyzed by Sidak’s multiple-comparison test. *P < 0.05, **P < 0.01, ***P < 0.001.



























































array of plasmids expressing, under control of the heat-inducible
promoter from hsp-16 genes, either the wild-type Orsay virus
RNA1 segment or a mutant RNA1 segment harboring an inacti-
vating mutation (D601A) in the RNA-dependent RNA polymer-
ase. The latter strain acts as a control to define levels of DNA-
templated transcription of the viral transgene. Heat induction of
hipr-1(vir12) transgenic strains carrying the wild-type viral RNA
transgene displayed intestinal GFP expression and Orsay virus
RNA1 replication comparable to levels observed in the wild-type
strain jyIs8;rde-1(ne219) harboring the same construct, while
transgenic strains expressing the polymerase-dead mutant did not
induce GFP expression or RNA1 replication (Fig. 5). Together,
these results demonstrated that Orsay virus replication initiated
from an endogenous transgene is not dependent on HIPR-1 and,
therefore, HIPR-1 acts at early steps upstream of Orsay virus
replication.
HIP1 and HIP1R, the Mammalian Orthologs of C. elegans HIPR-1, Are
Important for CVB3 Infection. Because HIP-family proteins are
evolutionarily conserved from yeast to humans (Fig. 3C), we
evaluated the roles of HIP1 and HIP1R in mammalian virus
infection. Both HIP1 and HIP1R knockout cells were generated
by CRISPR-Cas9 genome editing in A549 cells, a lung epithelial
carcinoma cell line (Fig. 6 A and D). Single-step infection by
CVB3 at a multiplicity of infection (MOI) of 1 showed ∼40%
reduction of infection in HIP1 knockout cells and ∼50% re-
duction of infection in HIP1R knockout cells compared with
control cells as quantified by flow cytometry analysis of CVB3-
positive cells (Fig. 6 B and E). In a multistep growth curve
analysis, a 10-fold reduction was seen at late time points of virus
infection in HIP1 knockout and HIP1R knockout cells (Fig. 6 C
and F). Although both HIP1 and HIP1R are thought to be im-
portant in endocytosis, using fluorescently labeled transferrin,
a canonical cargo for clathrin-mediated endocytosis, analysis
by flow cytometry demonstrated no defect in transferrin uptake
in any of the knockout cells (SI Appendix, Fig. S4), which is
consistent with previously reported transferrin endocytosis in
HIP1 and HIP1R knockout mouse embryonic fibroblast cells
(16, 21).
Ectopic lentivirus-mediated overexpression of HIP1 or HIP1R
in the corresponding knockout cells rescued CVB3 infection to
control cell levels (Fig. 6 J–M). To evaluate whether HIP1 and
HIP1R had synergistic roles in virus infection, a HIP1 and
HIP1R double-knockout A549 cell line was generated using the
same targeting single-guide RNAs (sgRNAs) (Fig. 6G). Infection
of the double mutant by CVB3 resulted in similar levels of re-
duction as either single mutant (Fig. 6H). Similarly, a multistep
growth analysis showed that HIP1 and HIP1R double-knockout
cells had similar 10-fold reduction of virus production as com-
pared with the control cells (Fig. 6I). The lack of an additive
effect of the HIP1/HIP1R knockout suggests that the two genes
might function in the same pathway.
HIP1 is known to bind to the N-terminal sequence of hun-
tingtin (34, 35). Thus, we tested whether overexpressing the hun-
tingtin N-terminal sequence would influence CVB3 infection.
Lentivirus-mediated expression of the 541-amino acid N termi-
nus of huntingtin in naïve A549 cells decreased infection by CVB3
as compared with control cells transduced to express firefly lucif-
erase (SI Appendix, Fig. S5).
To determine if CVB3 dependence on HIP1 and HIP1R was
specific to the A549 cell line, we evaluated HIP1, HIP1R, and
HIP/HIP1R knockouts in the Hap1 cell line, a hematopoietic
haploid cell line. Infection by CVB3 showed a similar reduction
phenotype in HIP1, HIP1R, and HIP1/HIP1R double knockouts
(SI Appendix, Fig. S6), demonstrating that their role in pro-
moting CVB3 infection is also conserved across multiple cell
types.
Fig. 5. Impact of hipr-1 on Orsay virus RNA replication induced from the
RNA1 transgene. (A) GFP expression of strains carrying wild-type or
polymerase-dead mutant Orsay virus RNA1 under a heat-inducible promoter
3 d after heat shock. A Pmyo2::YFP plasmid was coinjected as a transgenic
marker and is observed as GFP in the pharynx of transgenic animals. (Scale
bar, 100 μm.) PHIP, heat-inducible promoter; WT, wild type. (B) Quantifica-
tion of Orsay virus RNA1 replication 3 d after heat shock by real-time qRT-
PCR. The means and SDs for three replicates representative of at least two
independent biological experiments are shown. Statistically significant dif-
ferences were determined by Student’s t test. *P < 0.05, **P < 0.01.



















































Fig. 6. HIP1 and HIP1R are important for CVB3 infection. (A, D, G, J, and L) HIP1 and HIP1R expression in knockout and rescued cells detected byWestern blot.
(B, E, H, K, andM) FACS quantification of CVB3 infection on HIP1 and HIP1R knockout and rescued cells 8 h post inoculation. Fluc, firefly luciferase. (C, F, and I)
Multistep growth analysis of CVB3 on HIP1, HIP1R knockout, and double-knockout (DKO) cells. pfu, plaque-forming unit. The means and SDs for three
replicates representative of at least two independent biological experiments are shown. Statistically significant differences were determined by Student’s
t test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.



























































The Human HIP1 ANTH Domain Is Functional in C. elegans. To de-
termine if the human HIP1 ANTH domain is functional in C.
elegans, we ectopically expressed codon-optimized human HIP1
ANTH domain chimeric protein in the C. elegans HIPR-1 ex-
pression backbone by swapping in the human HIP1 ANTH do-
main (Fig. 7A). Ectopic expression in hipr-1(vir12) of the
construct carrying the human ANTH domain rescued both virus-
induced GFP expression and the Orsay virus RNA replication
phenotypes (Fig. 7 B and C). These data demonstrate that the
human ANTH domain of HIP1 is functional in C. elegans.
Discussion
There are only limited studies to date investigating the role of
HIP-family proteins in virus infection. No studies have previously
examined C. elegans HIPR-1 or its yeast ortholog, Sla2p, in the
context of viral infection. The human ortholog HIP1R is a hit in
an siRNA screen for Venezuelan equine encephalitis virus infection,
and both HIP1 and HIP1R are hits in hepatitis C virus, poliovirus,
and CVB3 infection screens. Although it has been suggested that
these HIP proteins likely function in clathrin-mediated endo-
cytosis to promote virus infection, the mechanism has not been
investigated fully (24–26). In this study, we exploited the power
of C. elegans forward genetic screens to define the essential role
of HIPR-1 in Orsay virus infection. Moreover, we determined
that HIPR-1’s function is dependent on its inositol phospho-
lipid- and F-actin–binding domains but independent of its cla-
thrin light chain-binding domain and clathrin heavy chain-
binding motif.
In human cells, we determined that both human orthologs of
C. elegans HIPR-1, HIP1 and HIP1R, were important for CVB3
infection in cell culture, demonstrating the evolutionary con-
servation of HIP-family proteins in supporting virus infection
from C. elegans to humans. In HIP1 and HIP1R double-knockout
cells, the absence of an additive effect on virus growth suggests
that HIP1 and HIP1R act in the same pathway to support virus
infection. It is known that HIP1 and HIP1R can form both
homodimers and heterodimers and this may be important for its
endocytic function (36–38). Thus, one plausible explanation is that
dimerization of HIP1 and HIP1R may play a role in promoting
virus infection. Consistent with our data demonstrating that
HIPR-1 in C. elegans acts in an early stage of Orsay virus infection,
the ∼50% reduction in CVB3-infected cells in single-step infection
suggests that HIP1 and HIP1R are likely important for an early
step of the virus life cyle. Further studies are required to deter-
mine whether these genes might also impact later stages of the
virus life cycle.
The two hipr-1 mutant alleles identified in this study pheno-
copy the viral replication and GFP induction defects observed in
the previously identified essential C. elegans host gene mutant
alleles sid-3, viro-2, and nck-1 (2). As the human orthologs of sid-
3, viro-2, and nck-1 have since been demonstrated to function in
a pathway (3), it is intriguing to speculate that hipr-1 may also be
part of this pathway. However, as all mutant alleles represent
null function for Orsay virus infection in C. elegans, any genetic
endeavor to reveal their relationship remains challenging in
C. elegans.
HIPR-1’s cellular function has not been well-defined in C.
elegans. However, models for its yeast and human orthologs
propose that HIP proteins are recruited to clathrin pits, where
they bind the plasma membrane, F-actin, and clathrin to mediate
initiation of endocytic vesicles (6, 8, 10). The domain analysis in
this study demonstrated that C. elegans HIPR-1’s inositol phos-
pholipid- and F-actin–binding domains are essential for its
function in Orsay virus infection, consistent with a model where
HIPR-1 couples the plasma membrane and F-actin to mediate
endocytosis. However, neither HIPR-1’s clathrin heavy chain-
binding motif nor its clathrin light chain-binding domain were
necessary for Orsay virus infection, suggesting that HIPR-1’s
function may be clathrin-independent. An alternative possibil-
ity is that HIPR-1 indirectly binds to clathrin through a separate
endocytic factor, as HIP proteins have been reported to bind to
other endocytic factors, such as to clathrin adaptor protein 2
(AP2) in human cells and Sla1p in yeast (20, 39). While C. ele-
gans HIPR-1 lacks the AP2 Asp-Pro-Phe (DPF)-binding motif
and there is no Sla1p ortholog in C. elegans, there may be ad-
ditional endocytic binding partners of HIPR-1. It is also plausible
that HIPR-1 may be mediating clathrin-mediated endocytosis
through a clathrin binding-independent mechanism.
Fig. 7. Domain swapping between C. elegans HIPR-1 and human HIP1. (A)
Domain structure for chimeric C. elegans HIPR-1 with the human HIP1 ANTH
domain. The gray numbers represent the amino acids introduced from the
human HIP1 ANTH for chimeric construction and the black numbers repre-
sent the C. elegans amino acid positions. (B) GFP reporter expression of
Orsay virus infection in the hipr-1(vir12) strain ectopically expressing C.
elegans HIPR-1 with the human ANTH domain. A Pmyo2::YFP plasmid was
coinjected as a transgenic marker and is observed as GFP in the pharynx of
transgenic animals. (Scale bar, 100 μm.) (C) Orsay virus RNA2 quantification
in the hipr-1(vir12) strain ectopically expressing C. elegans HIPR-1 with the
human ANTH domain. The means and SDs for three replicates representative
of at least two independent biological experiments are shown. Statistically
significant differences were determined by Student’s t test. ***P < 0.001.



















































The type of inositol phospholipids that C. elegans HIPR-1
binds to remains unknown. However, biochemical studies in the
yeast ortholog Sla2p have previously reported that it binds to
phosphatidylinositol (PtdIns)(4,5)P2 lipids (9), which are pri-
marily found at clathrin-coated pits at the cell surface and are
important for recruiting key endocytic machinery (40, 41). Bio-
chemical studies of the human orthologs HIP1 and HIP1R, in
contrast, show that they preferentially bind to PtdIns(3,4)P2,
PtdIns(3,5)P2, and, to a less extent, PtdIns(3)P (9), which are not
enriched at the cell surface but instead in early and late endo-
somes, and play an important role in endosomal trafficking and
protein sorting (42, 43). Together with the results from our
chimeric HIPR-1 experiments, which demonstrated that the
HIP1 ANTH domain was functional in C. elegans, it suggests
the possibilities that C. elegans HIPR-1 may be acting at or after
the internalization step of endocytosis during Orsay virus
infection.
In conclusion, our genetic studies have identified HIP-family
members as being evolutionarily conserved pro-viral host factors
from C. elegans to humans. Domain analysis elucidated that the
HIP protein’s inositol phospholipid-binding and F-actin–binding
abilities are critical for its pro-viral function in C. elegans, which
appears to be clathrin binding-independent. Furthermore, this
study established evidence of functional conservation between
HIP-family member domains across evolution through a C.
elegans–human chimeric protein. Collectively, these findings fur-
ther highlight the power of C. elegans in identifying novel evolu-
tionarily conserved host factors critical for virus infection, which
can ultimately lead to attractive targets for antiviral therapeutics.
Materials and Methods
An extended description of the materials and methods used in this study is
provided in SI Appendix, including the following: chemical mutagenesis
screen, genetic mapping of the phenotype-causing mutations in Viro-5 and
Viro-6, mCherry fluorescence quantification, transferrin uptake assay,
N-terminal huntingtin expression, and CVB3 infection.
C. elegans Culture and Maintenance. We obtained C. elegans strains
WM27 rde-1(ne219) and RB2519 drh-1(ok3495) from the Caenorhabditis
Genetics Center (CGC) and maintained them under standard laboratory
culture conditions unless otherwise specified (Table 1). In summary, animals
were fed Escherichia coli OP50 on nematode growth medium (NGM) plates
in a 20 °C incubator and chunked every 3 to 4 d to a new NGM plate seeded
with E. coli OP50.
Orsay Virus Preparation, Infection, and RNA Extraction. Orsay virus was pre-
pared by large-scale liquid culture as described previously (2) and filtered
through a 0.22-μm filter, and aliquots were stored at −80 °C. For all Orsay
virus infection experiments, animals were bleached and then synchronized
in M9 buffer in 15-mL conical tubes with constant rotation at room tem-
perature for 16 h. In six-well plates with 20 μL E. coli OP50, 500 arrested
larval stage 1 (L1) larvae were seeded. L1 larvae were allowed to recover for
20 h at 20 °C prior to infection. Orsay virus filtrate was thawed and brought
to room temperature and then a 1:10 dilution was made with M9 buffer. For
each well, 20 μL of virus filtrate was added to the middle of the bacterial
lawn and the infection was incubated at 20 °C. At 3 dpi, animals were col-
lected into 1.5-mL Eppendorf tubes by rinsing each well with 1 mL of M9
buffer and then spun down by spinning for 1 min at 3,000 rpm in a benchtop
centrifuge. M9 supernatant was removed, 300 μL TRIzol reagent (Invitrogen)
was added to the tubes, and they were frozen in liquid nitrogen. For Orsay
virus infection assays an input control was included consisting of input virus
that was incubated in an empty well for the duration of the experiment and
subsequently mixed with an uninfected well of animals immediately prior to
RNA extraction, to control for any degradation of the input virus in the
absence of any replication. For each experiment, three replicate wells
(technical replicates) were used for each infection condition, unless other-
wise indicated. Total RNA from infected animals was extracted using Direct-
zol RNA Miniprep (Zymo Research) purification according to the manufac-
turer’s protocol and eluted into 30 μL of RNase/DNase-free water. For all N.
parisii infection experiments, animals were bleached and then synchro-
nized in M9 buffer in 15-mL conical tubes with constant rotation at room
temperature for 16 h. In six-well plates with 20 μL E. coli OP50, 500 arrested
L1 larvae were seeded. L1 larvae were allowed to recover for 20 h at 20 °C
prior to infection. N. parisii spores were thawed and brought to room
temperature and then a 1:10 dilution was made with M9 buffer. For each
well, 20 μL of diluted N. parisii spores (10,000 spores per animal) was added
to the middle of the bacterial lawn and the infection was incubated at 20 °C.
At 3 dpi, animals were assayed for GFP fluorescence. For all of the infection
experiments, at least two independent biological experiments (performed
on different days) were performed.
C. elegans Feeding RNAi Knockdown. Genes were knocked down by RNAi
feeding as described previously (2). E. coli strain HT115 carrying double-
strand RNA expression cassettes for genes of interest was induced using
established conditions and then seeded into six-well NGM plates. dpy-3 and
hipr-1 RNAi clones were from the Ahringer RNAi library (44). Twenty
arrested L1 drh-1 mutant animals were seeded into each well of a six-well
plate. After 72 h of RNAi feeding, Orsay virus was added to the plates as
described above. At 2 dpi the animals were collected, and 300 μL of TRIzol
(Invitrogen) was added to each well for RNA extraction.
Orsay Virus Quantification by Real-Time qRT-PCR. RNA extracted from infected
animals was subjected to one-step real-time qRT-PCR to quantify Orsay virus
replication as previously described (2). The extracted RNA was diluted 1:100,
and 5 μL was used in a TaqMan Fast Virus 1-Step qRT-PCR with primers
GW303 and GW304 and probe Orsay_RNA2 (SI Appendix, Table S1) that
target the Orsay RNA2 segment. Primers GW314 and GW315 and probe
Orsay_RNA1 that target the Orsay virus RNA1 segment were used to quantify
Orsay virus RNA1 abundance. To control for variation in the number of ani-
mals per well, Orsay virus RNA levels were normalized to an internal control
gene, rps-20, which encodes a small ribosomal subunit S20 protein required for
translation in C. elegans, using primers KC291 and KC292 and probe rps-20_e3-
4. Absolute Orsay virus RNA2 and RNA1 and C. elegans rps-20 copy number
was determined by interpolation of a standard curve generated using serial
dilutions of in vitro transcripts of Orsay virus RNA2 and RNA1 and C. elegans
rps-20, respectively. The mean and SD for three replicate wells are shown for
all experiments. Statistical testing was done by Student’s t test or one-way
ANOVA. Statistically significant comparisons are indicated as follows:
****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05; NS, not significant (with
P > 0.05).
Forward Genetic Screen for Mutants That Fail to Activate GFP Expression
following Orsay Virus Infection. The jyIs8;rde-1 reporter strain was main-
tained on 10-cm plates seeded with 1.5 mL E. coli OP50. Animals were
grown to a stage with a high proportion of L4 larvae and were then col-
lected by rinsing the plates with water. Animals were then treated with
50 mM EMS for 4 h at 20 °C with constant rotation, washed with M9
buffer, and recovered on 10-cm plates for 6 h. Ten L4 P0 animals were
transferred to 10 new NGM plates and allowed to lay about 10 F1 eggs
each before being removed. F1 animals were washed away from plates
after laying about 20 eggs for each animal. Hatched F2 animals were
challenged with 800 μL of the standard virus filtrate dilution for infection
and screened for Viro mutants. For complementation assays, eight males
of one Viro mutant were crossed with two hermaphrodites of another Viro
mutant to define the ability of their progeny to complement the Viro
phenotypes.
Mapping the Causal Gene Mutation through F2 Bulk Segregant and CloudMap
Analysis. As previously described (2), hipr-1(vir13) mutants were crossed
with the WM27 rde-1(ne219) strain, and F1 progenies were chosen and
transferred to six-well plates. After 2 d, the F2 progenies were infected
with Orsay virus at the standard 1:10 dilution of the virus filtrate. At 3 dpi
of the F1 plates, 72 F2 Viro animals were picked off F1 plates and trans-
ferred to six-well plates. F2 plates were replicated after 2 d of laying eggs.
The original F2 plates were challenged again with Orsay virus, and both
GFP expression and viral RNA replication phenotypes were tested at 3 dpi.
Forty-two wells that yielded Viro animals and that yielded low RNA levels
from replicated F2 plates were pooled, and genomic DNA from the
pooled samples was extracted using a Qiagen genomic DNA preparation
kit according to the manufacturer’s protocol. DNA libraries were pre-
pared using a Nextera library preparation kit (New England Biolabs)
and then sequenced using Illumina MiSeq Standard. The raw sequence
data were analyzed using the pipeline CloudMap for C. elegans gene
mapping (27).



























































Plasmid Construction for hipr-1 Ectopic Expression. To construct the hipr-1
expression plasmid (Psur-5p::hipr-1), the entire hipr-1 gene was amplified
from N2 genomic DNA using primers LS188 and LS195 (SI Appendix, Table
S1). The PCR product was digested by SacII and NheI and subsequently li-
gated into the plasmid containing the sur-5 promoter as previously de-
scribed (2). To construct the hipr-1::mCherry expression plasmid (Psur-5::hipr-
1::mCherry), the hipr-1 gene lacking its stop codon was amplified from Psur-
5p::hipr-1 using primers LS188 and LS300 (SI Appendix, Table S1). The PCR
product was digested by SacII and NotI and then ligated into a plasmid
containing the sur-5 promoter and the mCherry gene with a 15-bp linker,
amino acid sequence SGAAA, at the 5′ end of mCherry. Primers for site-
directed mutations were generated by Agilent QuikChange Primer Design.
Site-directed mutagenesis primers LS396 and LS397, LS398 and LS399, and
LS400 and LS401 (SI Appendix, Table S1) were used to introduce the desired
amino acid substitutions for 3xY-F construct Y111F, Y118F, and Y211F, re-
spectively. Site-directed mutagenesis primers LS447 and LS448 (SI Appendix,
Table S1) were used to introduce the desired CHC motif deletion of amino
acids 307 to 311 into the Psur-5::hipr-1::mCherry plasmid. The NEBuilder HiFi
DNA Assembly Cloning Kit was used to generate the following three domain
deletions in the Psur-5::hipr-1::mCherry construct: a 933-bp deletion that
deleted parts of exons 1 and 3 and the entire intron 2 and corresponded to a
deletion of amino acids 11 to 285 (ANTH domain); a 1,368-bp deletion that
deleted exons 4 and 5, introns 3, 4, and 5, and parts of exons 3 and 6 and
corresponded to a deletion of amino acids 333 to 527 (coiled-coil domain);
and a 999-bp deletion that deleted parts of exons 8 and 9 and the entire
intron 8 and corresponded to a deletion of amino acids 713 to 917 (THATCH
domain). To generate the Psur-5::hipr-1::mCherry plasmid with a deletion of
both the CHC motif and coiled-coil domain, site-directed mutagenesis pri-
mers LS447 and LS448 (SI Appendix, Table S1) were used to introduce the
CHC motif deletion of amino acids 307 to 311 into the Psur-5::hipr-
1::mCherry plasmid that contained a deletion of amino acids 333 to 527
(coiled-coil domain).
To construct the human HIP1 ANTH domain expression construct in the C.
elegans HIPR-1 expression plasmid, C. elegans HIPR-1 complementary DNA
was reverse-transcribed, PCR-amplified using primers LS188 and LS195, and
then cloned into the Psur-5 expression vector. The corresponding human
HIP1 ANTH domain (primers HJ 454 and HJ 455) and the C. elegans HIPR-1
backbone (primers HJ 456 and HJ 457) were PCR-amplified with an ∼20-nt
overlapping region and FLAG-tagged at the C terminus. The resulting PCR
fragments were gel-purified and assembled with the Psur-5 expression
vector through the NEBuilder HiFi DNA Assembly Kit according to the
manufacturer’s protocol. Each plasmid sequence was confirmed by Sanger
sequencing.
Generating Transgenic Animals Transcomplemented with Plasmids Encoding
HIPR-1. For rescue of hipr-1(vir12) and hipr-1(vir13), an expression plasmid
containing the hipr-1 gene was injected into the mutant strain at a con-
centration of 5 ng/μL, along with 5 ng/μL of Pmyo-2::YFP as a transgenic
marker and 100 ng/μL of a 2-log DNA ladder (New England Biolabs) to help
establish the array. For rescue experiments in hipr-1(vir12) with HIPR-
1::mCherry or HIPR-1::mCherry(ΔCC) mutant constructs, the expression
plasmid containing either construct was injected into the mutant strain at a
concentration of 5 ng/μL, along with 5 ng/μL of Pmyo-2::YFP as a transgenic
marker and 100 ng/μL of a 2-log DNA ladder. For rescue experiments in
hipr-1(vir12) with HIPR-1::mCherry(ΔANTH), HIPR-1::mCherry(ΔCHC), HIPR-
1::mCherry(ΔTHATCH), HIPR-1::mCherry(3xY-F), or HIPR-1::mCherry(ΔCHCΔCC)
mutant constructs, the expression plasmid was injected into the mutant strain
at a concentration of 20 ng/μL, along with 5 ng/μL of Pmyo-2::YFP as a
transgenic marker and 100 ng/μL of a 2-log DNA ladder. For Orsay virus in-
fection experiments, five stable transgenic array-containing animals were
seeded into six-well plates with 20 μL E. coli OP50. After 72 h of egg laying,
Orsay virus was added to the plates as described above. At 3 dpi, animals were
assayed for GFP fluorescence and collected for RNA extraction and qRT-PCR to
assay virus replication. For heat induction experiments, five stable transgenic
array-containing animals were seeded into six-well plates with 20 μL E. coli
OP50. After 72 h of egg laying, animals were incubated at 33 °C for 2 h and
then maintained at 20 °C for 3 d. At 72 h after heat shock, animals were
assayed for GFP fluorescence and collected for RNA extraction and qRT-PCR to
assay virus RNA replication.
Table 1. Strains used in this study
Lab name Strain name Relevant genotype
WM27 rde-1(ne219) [rde-1(ne219)V]
RB2519 drh-1(ok3495) [drh-1(ok3495)IV]
WUM32 jyIs8;rde-1(ne219); virEx20[PHIP::RNA1WT-1] {virEx20[PHIP::OrsayRNA1WT-1; Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;Pmyo-2::mCherry];rde-1(ne219) V}
WUM33 jyIs8;rde-1(ne219); virEx21[PHIP::RNA1D601A-1] {virEx21[PHIP::OrsayRNA1D601A-1; Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;Pmyo-2::mCherry];rde-1(ne219) V}
WUM73 drl-1(vir11) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; drl-1(vir11)IV}
WUM78 hipr-1(vir12) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; hipr-1(vir12)III}
WUM79 hipr-1(vir13) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; hipr-1(vir13)III}
WUM80 hipr-1(vir12);virEx41[Psur-5::hipr-1] {virEx41[Psur-5::hipr-1;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP;P myo-
2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}
WUM81 hipr-1(vir12);virEx42[Psur-5::hipr-1::mCherry] {virEx42[Psur-5::hipr-1::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP;P
myo-2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}
WUM82 hipr-1(vir12);virEx43[Psur-5::hipr-1(ΔANTH)::mCherry] {virEx43[Psur-5::hipr-1(ΔANTH)::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;P myo-2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}
WUM83 hipr-1(vir12);virEx44[Psur-5::hipr-1(ΔCC)::mCherry] {virEx44[Psur-5::hipr-1(ΔCC)::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;P myo-2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}
WUM84 hipr-1(vir12);virEx45[Psur-5::hipr1(ΔTHATCH)::mCherry] {virEx45[Psur-5::hipr-1(ΔTHATCH)::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;P myo-2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}
WUM85 hipr-1(vir12);virEx46[Psur-5::hipr-1(ΔCHC)::mCherry] {virEx46[Psur-5::hipr-1(ΔCHC)::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;P myo-2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}
WUM86 hipr-1(vir12);virEx47[Psur-5::hipr-1(3xY-F)::mCherry] {virEx47[Psur-5::hipr-1(3xY-F)::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;P myo-2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}
WUM87 hipr-1(vir12); virEx48[PHIP::RNA1WT-1] {virEx48[PHIP::OrsayRNA1WT-1; Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;Pmyo-2::mCherry];rde-1(ne219) V; hipr-1(vir12)III}
WUM88 hipr-1(vir12); virEx49[PHIP::RNA1D601A-1] {virEx49[PHIP::OrsayRNA1D601A-1; Pmyo-2::YFP]; jyIs8[pals-
5::GFP;Pmyo-2::mCherry];rde-1(ne219) V; hipr-1(vir12)III}
WUM89 hipr-1(vir12);virEx50[Psur-5::hipr-1(Human ANTH):FLAG {virEx50[Psur-5::hipr-1(Human ANTH)::Flag;Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;P myo-2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}
WUM90 hipr-1(vir12);virEx51[Psur-5::hipr-1(ΔCHC ΔCC)::mCherry] {virEx51[Psur-5::hipr-1(ΔCHC ΔCC)::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-
5::GFP;P myo-2::mCherry];rde-1(ne219)V; hipr-1(vir12)III}



















































Phylogenetic Tree Construction. HIP protein amino acid sequences of different
species were downloaded from GenBank and aligned by ClustalX (version
2.1). A bootstrap neighbor-joining tree was generated by ClustalX (version
2.1). The number of bootstrap trials was set at 1,000 replicates. The radial
tree was exported from TreeView (version 1.6.6).
Epifluorescence Microscopy. The microscopic visual scanning analysis for Orsay
virus infection was carried out using a Leica stereo fluorescence microscope.
Images of C. elegans infections were acquired using a Zeiss Axio Imager M2
inverted fluorescence microscope equipped with a Hamamatsu Flash4.0
CMOS camera for fluorescence. Young adult to adult C. elegans animals
were anesthetized with 1 mM levamisole and then put on a 2% dry agarose
pad with a coverslip (5 by 5 cm) on top. Images were acquired from both
fluorescence channels and bright-field channels.
Cell Culture, Knockout Cell Line Generation, and Virus Infection. A549 cells
were obtained from the Michael Diamond laboratory. Cells were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) with 25 mM
Hepes, 2 mM L-glutamine, 1× nonessential amino acids, 10% fetal bovine
serum (FBS), and 100 U/mL antibiotics (penicillin and streptomycin).
Hap1 cells were obtained from Horizon and cultured in Iscove’s modified
Dulbecco’s medium with 10% FBS and 100 U/mL antibiotics. HeLa cells
were obtained from ATCC and cultured in DMEM with 10% FBS and 100
U/mL antibiotics. A549 cells were transduced by lentiviruses that express
the corresponding sgRNA (SI Appendix, Table S1) and Cas9 protein.
Transduced cells were passaged 2 d later and then selected with 2 μg/mL
puromycin for 7 d. Cells were passaged once during this selection. Clonal
selection was performed through limiting dilution in 96-well plates.
After 2 wk, single-cell clones were picked and expanded in 24-well
plates. The desired genome editing was identified by a restriction en-
zyme digestion-based genome typing assay and the ablation of protein
expression was confirmed by Western blot with anti-HIP1 monoclonal
antibodies 4B10 (Thermo Fisher Scientific) and anti-HIP1R monoclonal
antibodies 1E1 (Thermo Fisher Scientific). For infection quantification by
fluorescence-activated cell sorting (FACS) assay, cells were seeded 1 d
before infection into 96-well plates. Approximately 16 h after seeding,
cells were infected by CVB3 at an MOI of 1. One hour after infection, the
inoculum was removed and cells were cultured in DMEM with 2% FBS. At
8 h post infection, cells were trypsinized and fixed with 4% parafor-
maldehyde. Fixed cells were then permeabilized with perm buffer (1 g
saponin, 10 mM Hepes, 0.025% sodium azide in 1 L Hank’s balanced salt
solution) for 15 min. After permeabilization, cells were incubated with
primary antibodies for 1 h and then washed twice before incuba-
tion with fluorescently conjugated secondary antibodies. After 1 h of
secondary antibody incubation, cells were washed three times with
perm buffer and then resuspended with 70 μL of FACS buffer P2F
(phosphate-buffered saline with 2% FBS). Infected cells were then an-
alyzed and quantified through MACSQuant Analyzer flow cytometer
(Miltenyi Biotec). For multistep growth analysis, cells were infected by
CVB3 at an MOI of 0.01. One hour after inoculation, cells were washed
five times with serum-free DMEM and then cultured in DMEM with 2%
FBS. Culture supernatant was collected at times 0, 6, 12, 24, 36, and 48 h
post infection. Viruses released in the culture supernatant were titrated
on HeLa cells by plaque assay.
Data Availability. All study data are included in the article and SI Appendix.
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